Seven more large-scale trials (the TRIUMPH program, over 5,800 people total) are still running and will release results throughout 2026
The conversation highlights the strong bidirectional relationship between insulin resistance and thyroid dysfunction, including how each can worsen the other when left unaddressed
Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 13620, Korea Tel: +82-31-787-7035, Fax: +82-31-787-4051, E-mail: [email protected] Copyright 2024 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited
This triple-agonist mechanism has made retatrutide a focal point in metabolic and obesity research